Cerdelga® (eliglustat) Monitoring Tests, Plasma
What is Cerdelga (eliglustat)?
- Cerdelga (eliglustat) is an FDA approved medication for certain adults with Gaucher disease type 1.
- Physicians are encouraged to consult Genzyme Medical Information for test interpretation (see "Contact Genzyme" box)
|Reported||Within 7 days|
|New York DOH Approval||Pending|
|Interpretive Data||Contact Genzyme at firstname.lastname@example.org or by phone:
For US: (800) 745-4447 (option 2) or 617-768-9000 (option 2).
For international (Canada, Europe, Latin America, Japan, Asia Pacific): http://www.genzyme.com/contact-us.aspx and from the dropdown menu, select the Medical Information group in your region (US & Canada, Europe, Latin America, Japan, or Asia-Pacific).Results should be considered in conjunction with the patient’s clinical history and clinical presentation.
|CPT Code(s)||Not applicable|
|Test Request||Submit appropriately completed test request.|
No CPT codes are attached to this testing. The patient, their insurance company, or submitting facility should not be billed for the performance of the testing.